Autor: |
P I H G, Simons, O, Valkenburg, I, Telgenkamp, K M, van der Waaij, D M, de Groot, P, Veeraiah, J A P, Bons, T G J, Derks, C G, Schalkwijk, V B, Schrauwen-Hinderling, C D A, Stehouwer, M C G J, Brouwers |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Journal of endocrinological investigation. 45(6) |
ISSN: |
1720-8386 |
Popis: |
De novo lipogenesis has been inversely associated with serum sex hormone-binding globulin (SHBG) levels. However, the directionality of this association has remained uncertain. We, therefore, studied individuals with glycogen storage disease type 1a (GSD1a), who are characterized by a genetic defect in glucose-6-phosphatase resulting in increased rates of de novo lipogenesis, to assess the downstream effect on serum SHBG levels.A case-control study comparing serum SHBG levels in patients with GSD1a (n = 10) and controls matched for age, sex, and BMI (n = 10). Intrahepatic lipid content and saturated fatty acid fraction were quantified by proton magnetic resonance spectroscopy.Serum SHBG levels were statistically significantly lower in patients with GSD1a compared to the controls (p = 0.041), while intrahepatic lipid content and intrahepatic saturated fatty acid fraction-a marker of de novo lipogenesis-were significantly higher in patients with GSD1a (p = 0.001 and p = 0.019, respectively). In addition, there was a statistically significant, inverse association of intrahepatic lipid content and saturated fatty acid fraction with serum SHBG levels in patients and controls combined (β: - 0.28, 95% CI: - 0.47;- 0.09 and β: - 0.02, 95% CI: - 0.04;- 0.01, respectively).Patients with GSD1a, who are characterized by genetically determined higher rates of de novo lipogenesis, have lower serum SHBG levels than controls. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|